Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

PHiNE Bio AG

History from 9 Jul 2025

UID
CHE-361.639.629
Legal form
AG
Canton
BS
Founded
9 Jul 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 125k
31k62k94k125k6 Jan 2026 · CHF 125k2026
  • shares

Record

  1. Company formed

    Founded 9 Jul 2025

    SHAB HR01-1006383644 ↗
  2. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 125’000
    Shares
    1’000’000 → 1’250’000
    New shares, % of post-step shares
    20.0% (250’000 new)

    Aktienkapital neu: CHF 125'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 75'000.00 [bisher: CHF 50'000.00]. Aktien neu: 1'250'000 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006529513 ↗

Published by 11 Jan 2026

Latest available record · 8 Oct 2026